PHENYTOIN BINDING TO PARTIALLY PURIFIED ALBUMIN IN RENAL-DISEASE

被引:31
|
作者
KINNIBURGH, DW
BOYD, ND
机构
[1] UNIV CALGARY,FAC MED,DEPT MED BIOCHEM,CALGARY T2N 1N4,ALBERTA,CANADA
[2] UNIV CALGARY,DEPT PATHOL,CALGARY T2N 1N4,ALBERTA,CANADA
[3] FOOTHILLS HOSP,DEPT LABS,CALGARY,ALBERTA,CANADA
关键词
D O I
10.1038/clpt.1981.32
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:203 / 210
页数:8
相关论文
共 50 条
  • [1] BINDING-CAPACITY OF ALBUMIN AND RENAL-DISEASE
    DROMGOOLE, SH
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1974, 191 (02) : 318 - 323
  • [2] PHENYTOIN IN END-STAGE RENAL-DISEASE
    KAPLAN, B
    KRUMLOVSKY, FA
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1992, 15 (02) : 69 - 70
  • [3] ALBUMIN AND CREATININE CLEARANCES IN RENAL-DISEASE
    LAVENDER, S
    BENNETT, J
    MORSE, PF
    POLAK, A
    CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1974, 46 (01): : P3 - P3
  • [4] ALBUMIN AND CREATININE CLEARANCES IN RENAL-DISEASE
    LAVENDER, S
    BENNETT, J
    MORSE, PF
    POLAK, A
    CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1974, 46 (06): : 775 - 784
  • [5] DRUG-BINDING AND RENAL-DISEASE
    ODARCEDERLOF, I
    ACTA PHARMACEUTICA SUECICA, 1980, 17 (02): : 103 - 104
  • [6] PROTEIN-BINDING OF PHENYTOIN, PARA-HYDROXY PHENYTOIN (HPPH), AND HPPH GLUCURONIDE (HPPHG) IN PATIENTS WITH END-STAGE RENAL-DISEASE
    MATZKE, GR
    SAWCHUK, RJ
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (06): : 443 - 444
  • [7] METHOD-DEPENDENCE OF SERUM PHENYTOIN MEASUREMENTS IN PATIENTS WITH RENAL-DISEASE
    LEWIS, SC
    CLINICAL CHEMISTRY, 1983, 29 (06) : 1276 - 1276
  • [8] DRUG-PROTEIN BINDING IN RENAL-DISEASE
    RIANT, P
    BARRE, J
    ALBENGRES, E
    LEMAIRE, M
    TILLEMENT, JP
    NEPHROLOGIE, 1986, 7 (03): : 89 - 93
  • [9] ALTERATION OF DRUG-PROTEIN BINDING IN RENAL-DISEASE
    REIDENBERG, MM
    DRAYER, DE
    CLINICAL PHARMACOKINETICS, 1984, 9 : 18 - 26
  • [10] THE PLASMA-PROTEIN BINDING OF THEOPHYLLINE IN RENAL-DISEASE
    LEOPOLD, D
    WEBB, D
    BUSS, D
    FIFIELD, RA
    ROUTLEDGE, PA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (02) : P229 - P230